Answer
Clinical pharmacokinetic assessments indicated no clinically relevant interactions between daratumumab and lenalidomide, pomalidomide, thalidomide, bortezomib or dexamethasone, although no interaction studies have been performed.
Sources for this answer
- DARZALEX 20 mg/mL concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.5 Interaction with other medicinal products · Version 34Document updated
Sources checked